Feldan Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) (NCT07670858) | Feldan Therapeutics | 2024-10-30 |
Track Feldan Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.